| The underexposed role of food matrices in probiotic products: Reviewing the relationship between carrier matrices and product parameters J Flach, MB van der Waal, M van den Nieuwboer, E Claassen, ... Critical reviews in food science and nutrition 58 (15), 2570-2584, 2018 | 93 | 2018 |
| Probiotic research priorities for the healthy adult population: A review on the health benefits of Lactobacillus rhamnosus GG and Bifidobacterium animalis subspecies lactis BB-12 J Flach, MB van der Waal, AFM Kardinaal, J Schloesser, R Ruijschop, ... Cogent Food & Agriculture 4 (1), 1452839, 2018 | 36 | 2018 |
| Probiotics for improving quality of life in ulcerative colitis: Exploring the patient perspective MB van der Waal, J Flach, PD Browne, I Besseling-van der Vaart, ... Pharmanutrition 7, 100139, 2019 | 27 | 2019 |
| Blockchain-facilitated sharing to advance outbreak R&D MB van der Waal, CS Ribeiro, M Ma, GB Haringhuizen, E Claassen, ... Science 368 (6492), 719-721, 2020 | 24 | 2020 |
| Accelerating microbiota product development: The Societal Impact Value Cycle as a conceptual model to shape and improve public-private valorization processes LHM Van de Burgwal, MB Van der Waal, E Claassen PharmaNutrition 6 (4), 157-168, 2018 | 24 | 2018 |
| Medical doctors’ perceptions on probiotics: Lack of efficacy data hampers innovation J Flach, ASM Dias, SHM Rademaker, MB van der Waal, E Claassen, ... PharmaNutrition 5 (3), 103-108, 2017 | 24 | 2017 |
| The Nagoya Protocol on Access to Genetic Resources and Benefit Sharing: Best practices for users of Lactic Acid Bacteria J Flach, CS Ribeiro, MB van der Waal, RX van der Waal, E Claassen, ... PharmaNutrition 9, 100158, 2019 | 16 | 2019 |
| Towards improved process efficiency in vaccine innovation: The Vaccine Innovation Cycle as a validated, conceptual stage-gate model LHM Van de Burgwal, CDS Ribeiro, MB Van der Waal, E Claassen Vaccine 36 (49), 7496-7508, 2018 | 14 | 2018 |
| Economic potential of probiotic supplementation in institutionalized elderly with chronic constipation J Flach, M Koks, MB van der Waal, E Claassen, OFA Larsen PharmaNutrition 6 (4), 198-206, 2018 | 11 | 2018 |
| Leveraging academic knowledge in the innovation ecosystem L van de Burgwal, M van der Waal, E Claassen | 11 | 2018 |
| Multispecies probiotics promote perceived human health and wellbeing: insights into the value of retrospective studies on user experiences AM van der Geest, I Besseling-van der Vaart, EM Schellinger-de Goede, ... Beneficial microbes 12 (5), 413-430, 2021 | 7 | 2021 |
| To patent or not to patent? Consideration of the societal aspects of patenting across pharma-nutrition industries JJ Feddema, MB van der Waal, MJ Renes, E Claassen, ... PharmaNutrition 16, 1-3, 2021 | 7 | 2021 |
| A critical appreciation of intangible resources in PharmaNutrition MB van der Waal, CK Veldhuizen, RX van der Waal, E Claassen, ... PharmaNutrition 13, 100208, 2020 | 4 | 2020 |
| Market Knowledge and Stakeholder Considerations for the Biopharmaceutics Sector—Incorporating User Value and Societal Needs in Therapeutic Interventions JK Timmis, RX Van Der Waal, J Herz, MB Van Der Waal, E Claassen, ... Health 13 (11), 1365-1395, 2021 | 3 | 2021 |
| Infant and child microbiota: current status and directions for future research PD Browne, MB Van der Waal, E Claassen Microbiota in health and disease: from pregnancy to childhood, 17-35, 2017 | 1 | 2017 |
| Untangling the Intangible: Insights on Managing the Complex Dynamics of Intellectual Capital for Cooperative Innovation in the Life Sciences MB van der Waal | | 2024 |
| Blockchain-Based Dynamic Consent and its Applications for Patient-Centric Research and Health Information Sharing: Protocol for an Integrative Review WM Charles, MB van der Waal, J Flach, A Bisschop, RX van der Waal, ... JMIR Research Protocols 13 (1), e50339, 2024 | | 2024 |
| Mapping the broad societal impact of patents MB van der Waal, JJ Feddema, LHM van de Burgwal Technovation 128, 102876, 2023 | | 2023 |
| Triall Whitepaper: A digital ecosystem for clinical trials RX van der Waal, J Flach, MB van der Waal | | 2019 |
| Triall Whitepaper R van der Waal, J Flach, M van der Waal | | 2019 |
Joost FlachVrije Universiteit AmsterdamVerified email at vu.nl
